Trump administration announces drug pricing deals with Teva, Astellas and others
The companies will offer lower prices tied to other wealthy countries and give state Medicaid programs discounts, the White House said.
- The Trump Administration announced new drug pricing deals with companies including Teva Pharmaceuticals to lower Medicaid medicine costs in the U.S. by aligning prices with other developed countries under the GENEROUS framework.
- Teva Pharmaceuticals committed to maintaining investment in scientific innovation and U.S. pharmaceutical manufacturing while supporting active pharmaceutical ingredient reserves for public health.
39 Articles
39 Articles
Trump administration announces drug pricing deals with Teva, Astellas and others
U.S. President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and some smaller biotechs on Monday, part of a push to make healthcare more affordable for Americans.
Trump’s Drug Pricing Deals Are a Farce
President Donald Trump is expected to announce more most-favored nation (MFN) drug pricing deals with additional pharmaceutical companies today. Public Citizen plans to immediately file a Freedom of Information request to obtain the texts of the newly claimed White House deals. Peter Maybarduk, Acce...
Trump announces nine most-favored-nation deals to lower drug prices
The Trump administration announced nine new drug price reduction deals with midsize pharmaceutical companies in an effort to continue lowering prescription drug costs ahead of the November midterm elections. President Donald Trump said Monday during an Oval Office event that the new deals are “as big as it gets medically.” “It’s the largest drug discount, the largest price reductions in the history of medicine,” Trump said. “I would say that’s p…
Coverage Details
Bias Distribution
- 56% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
